XTLB
XTL Biopharmaceuticals
XTLB
XTLB
4 hedge funds and large institutions have $848K invested in XTL Biopharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.
Holders
4
Holders Change
+1
Holders Change %
+33.33%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$90K |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$2K |
Top Sellers
No sellers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
NC
1
Noked Capital
Tel Aviv,
Israel
| $378K | 198,888 | – | – |
|
|
NI
2
Noked Israel
Ramat Hasharon,
Israel
| $378K | 198,888 | – | – |
|
|
3
Morgan Stanley
New York
| $90K | 47,431 | +5,600 | +13% |
|
|
4
UBS Group
Zurich,
Switzerland
| $2K | 1,036 | +1,036 | New |
|
|
CFGS
5
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|